Changchun BCHT Biotechnology Co. (SHA:688276)
China · Delayed Price · Currency is CNY 20.10
+0.20 (1.01%)
At close: Feb 3, 2026
SHA:688276 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -170.53 | 232.09 | 501.01 | 181.54 | 243.55 | 418.23 |
Depreciation & Amortization | 104.18 | 104.18 | 91.99 | 70.94 | 68.34 | 58.86 |
Other Amortization | 9.15 | 9.15 | 7.01 | 5.68 | 0.99 | 0.66 |
Loss (Gain) From Sale of Assets | 2.55 | 2.55 | 0.9 | 0.73 | 2.19 | - |
Asset Writedown & Restructuring Costs | 0.78 | 0.78 | - | - | - | 0.05 |
Loss (Gain) From Sale of Investments | 0.44 | 0.44 | -0.69 | -0.31 | 1.02 | -6.42 |
Provision & Write-off of Bad Debts | 6.13 | 6.13 | 31.67 | 12.54 | 5.35 | -0.61 |
Other Operating Activities | 198.76 | 40.06 | 55.96 | 41.34 | 82.59 | 4.04 |
Change in Accounts Receivable | 121.92 | 121.92 | -691.36 | -171.36 | -40.04 | -418.58 |
Change in Inventory | 20.66 | 20.66 | -33.53 | 7.89 | -166.47 | -59.72 |
Change in Accounts Payable | -127.49 | -127.49 | 327.65 | -109.1 | -51.67 | 224.57 |
Operating Cash Flow | 162.59 | 406.5 | 255.21 | 39.82 | 140.3 | 209.16 |
Operating Cash Flow Growth | -55.40% | 59.28% | 540.93% | -71.62% | -32.92% | -10.15% |
Capital Expenditures | -386.66 | -542.43 | -470.66 | -290.73 | -632.88 | -335.75 |
Sale of Property, Plant & Equipment | - | - | 0.04 | - | 0.02 | - |
Investment in Securities | -50 | - | -168 | - | -62.64 | - |
Other Investing Activities | - | 0.94 | - | 2.02 | - | 2.16 |
Investing Cash Flow | -436.66 | -541.48 | -638.63 | -288.72 | -695.51 | -333.59 |
Short-Term Debt Issued | - | - | - | - | 67.5 | 69.9 |
Long-Term Debt Issued | - | 336.84 | 196.91 | - | - | - |
Total Debt Issued | 349.85 | 336.84 | 196.91 | - | 67.5 | 69.9 |
Short-Term Debt Repaid | - | - | - | - | -67.5 | -234.9 |
Long-Term Debt Repaid | - | -254.48 | -176.44 | - | - | - |
Total Debt Repaid | -116.34 | -254.48 | -176.44 | - | -67.5 | -234.9 |
Net Debt Issued (Repaid) | 233.51 | 82.36 | 20.47 | - | - | -165 |
Issuance of Common Stock | - | 19 | - | - | 1,413 | 350 |
Common Dividends Paid | -72.02 | -62.05 | -62.61 | -41.28 | - | - |
Other Financing Activities | -2.35 | -2.35 | - | - | -10.4 | -10.61 |
Financing Cash Flow | 159.14 | 36.97 | -42.14 | -41.28 | 1,402 | 174.39 |
Foreign Exchange Rate Adjustments | 0.11 | 0.7 | 0.5 | 1.66 | -0.1 | -0.1 |
Net Cash Flow | -114.81 | -97.31 | -425.06 | -288.52 | 847.05 | 49.86 |
Free Cash Flow | -224.07 | -135.92 | -215.46 | -250.91 | -492.58 | -126.58 |
Free Cash Flow Margin | -33.07% | -11.06% | -11.81% | -23.42% | -40.98% | -8.78% |
Free Cash Flow Per Share | -0.54 | -0.33 | -0.52 | -0.61 | -1.25 | -0.34 |
Cash Interest Paid | 2.35 | 2.35 | - | - | 0.33 | 4.05 |
Cash Income Tax Paid | 42.35 | 139.52 | 121.49 | 77.93 | 102.54 | 121.75 |
Levered Free Cash Flow | -48.17 | -213.55 | -334.43 | -297.86 | -467.9 | -177.89 |
Unlevered Free Cash Flow | -46.48 | -212.6 | -333.99 | -297.86 | -467.69 | -175.35 |
Change in Working Capital | 11.12 | 11.12 | -432.65 | -293.73 | -269.15 | -265.65 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.